Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing their first treatment cycle of IVF or ICSI

References

• Fevold HL. Synergism of follicle stimulating and luteinizing hormones in producing estrogen secretion. Endocrinology. 1941;28:33–6.
   Google Scholar
• Ryen KJ, Petro Z, Kaiser J. Steroid formation by isolated and recombinant ovarian granulosa and theca cells. J Clin Endocrinol Metab. 1968;67:889–99.
   Google Scholar
• Van Wely M, Westergaard LG, Bossuyt PMM, Van der Veen F. Human menopausal gonadotropin versus recombinant follicle stimulation hormone of ovarian stimulation in assisted reproductive cycles. Cochrane Database Syst Rev. 2003:CD003973.
   Google Scholar
• Westergaard LG, Erb K, Laursen SB, Rex S, Rasmussen PE. Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmatic sperm injection: a prospective randomized study. Fertil Steril. 2002;76:543–9.
   Google Scholar
• European and Israeli Study Group on Highly Purified Menotrophin versus Recombinant Follicle-Stimulating Hormone 2002. Efficacy and safety of highly purified menotrophins versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized comparative trial. Fertil Steril. 2002;78:520–8.
   Google Scholar
• Platteau P, Smitz J, Albano C, Sørensen P, Arce JC, Devroey P. Exogenous luteinizing hormone may influence the treatment outcome in in vitro fertilization but not in intracytoplasmatic sperm injection cycles. Fertil Steril. 2004;81:1401–4.
   PubMed Web of Science ®Google Scholar
• Arce JC, Nyboe Andersen A, Collins J. Resolving methodological and clinical issues in the design of efficacy in assisted reproduction technologies: a mini-review. Hum Reprod. 2005;20:1757–71.
   Google Scholar
• Nyboe Andersen A, Devroey P, Arce JC. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod. 2006;21:3217–27.
   PubMed Web of Science ®Google Scholar
• Platteau P, Nyboe Andersen A, Loft A, Smitz J, Danglas P, Devroey P. Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cycles. Reprod Biomed Online. 2008;17:190–8.
   PubMedGoogle Scholar
• Coomarasamy A, Masoud A, Cheema D, van der Veen, Bossuyt PMM, van Wely M. Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis. Hum Reprod. 2008;23:310–5.
   PubMed Web of Science ®Google Scholar
• Daya S. Pitfalls in the design and analysis of efficiency trials in subfertility. Hum Reprod. 2003;18:1005–9.
   PubMed Web of Science ®Google Scholar
• Meldrum DR, Silverberg KM, Bustillo M, Stokes L. Success rate with repeated cycles of in vitro fertilization-embryo transfer. Fertil Steril. 1998;69:1005–9.
   PubMed Web of Science ®Google Scholar
• Hompes PGA, Broekmans FJ, Hoozemans DA, Schats R. Effectiveness of highly purified menopausal gonadotrophin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmatic sperm injection patients. Fertil Steril. 2008;89:1685–93.
   PubMed Web of Science ®Google Scholar
• Tanbo T, Dale PO, Lunde O, Norman N, Abyholm T. Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulating hormone levels. Fertil Steril. 1992;57:819–24.
   Google Scholar
• Brindsen P, Akagbosu F, Gibbons LM, Lancaster S, Gourdon D, Engrand P, A comparison of the efficiency and tolerability of two recombinant human follicle-stimulating hormone preparations in patients undergoing in vitro fertilization transfer. Fertil Steril. 2000;73:114–16.
   Google Scholar
• Veeck LL. Human oocytes at the time of follicular harvest. In: Brown C-L (ed). Atlas of the human oocyte and early conception, 1st edn. Baltimore: Williams and Wilkins, 1986. pp. 5–109.
   Google Scholar
• Van den Abbeel E, Van der Elst J, Van Waesberghe L, Camus M, Devroey P, Khan I, Hyperstimulation: the need for cryopreservation of embryos. Hum Reprod 1988;3(Suppl 2):53–7.
   Google Scholar
• Smitz J, Nyboe Andersen A, Devroey P, Arce JC. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum Reprod. 2007;22:676–87.
   PubMed Web of Science ®Google Scholar
• Lisi F, Rinaldi L, Fishel S, Pepe GP, Picconeri MG, Campbell A, Use of recombinant FSH and recombinant LH I multiple follicular stimulation for IVF: a preliminary study. Reprod Biomed Online. 2001;3:1990–4.
   Google Scholar
• Lisi F, Rinaldi L, Fishel S, Lisi R, Pepe GP, Picconeri MG, Use of recombinant LH in a group of unselected IVF patients. Reprod Biomed Online. 2002;5:104–8.
   PubMedGoogle Scholar
• De Placido GA, Alviggi C, Mollo A, Strina I, Ranieri A, Alviggi E, Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation. Clin Endocrinol (Oxford). 2004;60:637–43.
   PubMed Web of Science ®Google Scholar
• Ferraretti R, Peltier E, Frydman R. Exogenous luteinization hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril. 2004;82:1521–6.
   PubMed Web of Science ®Google Scholar
• De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolini A, ; Italian Collaborative Group on Recombinant Human Luteinizing Hormone. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod. 2005;20:390–6.
   PubMed Web of Science ®Google Scholar
• Bosch E, Pau E, Albert C, Zuzuarregui J, Remohi J, Pellicer A. Impact of different amounts of LH in controlled ovarian hyperstimulation oocyte donation cycles. Fertil Steril. 2006;86:S425.
   Google Scholar
• Al-Inany HG, Abou-Setta AM, Anoulghar MA, Mansour RT, Serour GI. Efficacy and safety of human menopausal gonadotrophins versus recombinant FSH: a meta-analysis. Reprod Biomed Online. 2007;16:81–8.
   Google Scholar
• Bjercke S, Fedorcsak P, Åbyholm T, Storeng R, Ertzeid G, Oldereid N, IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression. Hum Reprod. 2005;20:2441–7.
   PubMed Web of Science ®Google Scholar
• Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod. 2009;24:867–75.
   PubMed Web of Science ®Google Scholar
• Hofmann GE, Bergh PA, Guzman I, Masuku S, Navot D. Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotrophin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle. Hum Reprod. 1993;8:695–8.
   Google Scholar
• Ubaldi F, Camus M, Smitz J, Bennink HJTC, Van Steirteghem A, Devroey P. Premature luteinization in in vitro fertilization cycles using gonadotrophin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulation hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril. 1996;66:275–80.
   Google Scholar
• Filicori M, Cognigni GE, Pocognoli P, Tabarelli C, Spettoli D, Taraborelli S, Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration. Hum Reprod. 2002;17:2009–15.
   PubMed Web of Science ®Google Scholar
• Fanchin R, Righini C, Ayoubi J-M, Olivennes F, de Ziegler D, Frydman R. New look at endometrial echogenicity: objective computer-assisted measurement predicts endometrial receptivity in in vitro fertilization-embryo transfer. Fertil Steril. 2000;74:274–81.
   PubMedGoogle Scholar